series-a
Stage
1
Investors
About
Oncorena develops a first-in-class treatment using orellanine for metastatic renal cancer, aiming to provide a breakthrough therapy for patients with this fatal disease.
Explore Oncorena's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.